Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size & Outlook
The global blastic plasmacytoid dendritic cell neoplasm market size was estimated at USD 127.7 million in 2023 and is projected to reach USD 214.3 million by 2030, growing at a CAGR of 7.7% from 2024 to 2030.
Revenue, 2023 (US$M)
$127.7
Forecast, 2030 (US$M)
$214.3
CAGR, 2024 - 2030
7.7%
Report Coverage
Worldwide
Global blastic plasmacytoid dendritic cell neoplasm market, 2018-2030 (US$M)
Related Markets
Global blastic plasmacytoid dendritic cell neoplasm market highlights
- The global blastic plasmacytoid dendritic cell neoplasm market generated a revenue of USD 127.7 million in 2023 and is expected to reach USD 214.3 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 7.7% by 2030.
- In terms of segment, chemotherapy accounted for a revenue of USD 127.7 million in 2023.
- Chemotherapy is the most lucrative treatment segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
Global data book summary
| Market revenue in 2023 | USD 127.7 million |
| Market revenue in 2030 | USD 214.3 million |
| Growth rate | 7.7% (CAGR from 2024 to 2030) |
| Largest segment | Chemotherapy |
| Fastest growing segment | Chemotherapy |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Chemotherapy |
Other key industry trends
- In terms of revenue, the North America accounted for 39.5% of the global blastic plasmacytoid dendritic cell neoplasm market in 2023.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blastic Plasmacytoid Dendritic Cell Neoplasm Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Xencor | View profile | 251-500 | Monrovia, California, United States, North America | http://xencor.com |
| Cellex | View profile | 251-500 | Köln, Nordrhein-Westfalen, Germany, Europe | https://www.cellex.me/en |
| Stemline Therapeutics | View profile | 11-50 | New York, New York, United States, North America | http://www.stemline.com |
| ImmunoGen | View profile | 501-1000 | Waltham, Massachusetts, United States, North America | http://www.immunogen.com |
| Jazz Pharmaceuticals PLC | View profile | 2800 | Waterloo Road, Fifth Floor, Waterloo Exchange, Dublin, Ireland, D04 E5W7 | https://www.jazzpharmaceuticals.com |
| Genentech | View profile | 10001+ | South San Francisco, California, United States, North America | http://gene.com |
| Resverlogix Corp | View profile | 18 | 4820 Richard Road South West, Suite 300, Calgary, AB, Canada, T3E 6L1 | https://www.resverlogix.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
Global blastic plasmacytoid dendritic cell neoplasm market size, by regions, 2018-2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
